PROFUND ADVISORS LLC - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 216 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2023. The put-call ratio across all filers is 2.45 and the average weighting 0.2%.

Quarter-by-quarter ownership
PROFUND ADVISORS LLC ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q3 2023$1,439,456
-13.9%
28,663
+8.4%
0.08%
-11.1%
Q2 2023$1,670,882
+21.4%
26,438
-13.6%
0.09%
+5.9%
Q1 2023$1,376,694
+288.0%
30,600
+277.9%
0.08%
+269.6%
Q4 2022$354,773
-32.0%
8,098
+2.1%
0.02%
-39.5%
Q3 2022$522,000
+27.9%
7,928
-1.8%
0.04%
+46.2%
Q2 2022$408,000
-29.5%
8,077
-10.9%
0.03%
+8.3%
Q1 2022$579,000
-46.3%
9,062
-10.0%
0.02%
-31.4%
Q4 2021$1,079,000
-6.4%
10,070
-10.2%
0.04%
-10.3%
Q3 2021$1,153,000
+12.3%
11,211
-4.0%
0.04%
+14.7%
Q2 2021$1,027,000
-11.2%
11,675
-1.9%
0.03%
-22.7%
Q1 2021$1,157,000
-17.7%
11,902
-5.1%
0.04%
-27.9%
Q4 2020$1,406,000
+34.7%
12,537
+11.3%
0.06%
+13.0%
Q3 2020$1,044,000
+3.7%
11,261
-12.8%
0.05%
-3.6%
Q2 2020$1,007,000
+72.4%
12,910
+29.3%
0.06%
+27.3%
Q1 2020$584,000
-48.2%
9,985
-29.1%
0.04%
-10.2%
Q4 2019$1,128,000
+24.5%
14,078
+14.2%
0.05%
+6.5%
Q3 2019$906,00012,3290.05%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q3 2023
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 379,090$19,037,90017.25%
DAFNA Capital Management LLC 249,521$12,530,9453.90%
Rock Springs Capital Management LP 2,685,294$134,855,4653.61%
Casdin Capital, LLC 371,378$18,650,6032.06%
Novo Holdings A/S 525,000$26,365,5001.95%
CHI Advisors LLC 92,888$4,664,8351.85%
SECTORAL ASSET MANAGEMENT INC 165,890$8,330,9961.62%
Avidity Partners Management LP 751,600$37,745,3521.52%
EMERALD ADVISERS, LLC 607,037$30,485,3931.48%
EMERALD MUTUAL FUND ADVISERS TRUST 464,321$23,318,2011.41%
View complete list of BLUEPRINT MEDICINES CORP shareholders